News and Comments

PERRIGO ACQUIRES ELAN

Prohost Biotech - Monday, July 29, 2013

Elan is Taken over by Perrigo in a transaction that involves cash and shares of Perrigo.  For the details of the transaction, the press release and the PDF presentation by the New Perrigo Prohost subscribers can click on TODAY'S HIGHLIGHTS at this Website. 

This transaction was predictable. Congratulation for Prohost subscribers who kept the stock even during the time when the stock had tumbled under tremendous pressure by the market evaluators.  

FORWARD-LOOKING: Material presented here is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock you should do your own research and reach your own conclusion. Further, these are our 'opinions' and we may be wrong. We may have positions in securities mentioned in this article. You should take this into consideration before acting on any advice given in this article. If this makes you uncomfortable, then do not listen to our thoughts and opinions. The contents of this article do not take into consideration your individual investment objectives so consult with your own financial adviser before making an investment decision. Investing includes certain risks including loss of principal.


Comments
Post has no comments.
Post a Comment




Captcha Image

Trackback Link
http://www.prohostbiotech.com/BlogRetrieve.aspx?BlogID=8883&PostID=1086420&A=Trackback
Trackbacks
Post has no trackbacks.

Recent Postings


Archive


Tags

CompuGen (CGEN) Sarepta (SRPT) VANDA (VNDA) Zerenex ImmunoGen (IMGN) Anacor (ANAC) Prolor Biotech (PBTH) NOVOCURE (NVCR) RenenxBio (RGNX) Intercept (ICPT) Xoma (XOMA) Roche (ROCHE) Human Genome Sciences (HGSI) Sanofi (SNY) Seattle Genetics (SGEN) Revlimid (lenolidamide) Sequenom (SQNM) AERIE PHARMACEUTICALS Jazz Pharmaceuticals (JAZZ) SUNESIS PHARMACEUTICALS (SNSS) Advaxis (ADXS) Global Cell Therapeutics (GBT) ISIS (ISIS) SERES THERAPEUTICS (MCRB) ZALTRAP™ Editas (EDIT) GUARDIAN HEALTH Human Longevity (HLI) Illumina (ILMN) Pluristem (PSTI) Exelixis (EXEL) ACADIA (ACAD) Dynavax (DVAX) KITE (KITE) Aimmune Therapeutics (AIMT) Theravance (THRX) PTC Therapeutics (PTCT) Vertex (VRTX) Array Pharmaceuticals (ARRY) Intermune (ITMN) Ziofpharm (ZIOP) Auspex (ASPX) Multiple Myeloma Agenus (AGEN Galena (GALE) Elan (ELN) BIOMARIN (BMRN) OSI (OSIP) Alder Biopharmaceuticals (ALDR) Abbott Laboratories (ABT) Bristol-Myers Squibb (BMY) Endometrial Cancer Sanofi-Aventis (SAN) Trastuzumab-DM1 NEKTAR (NKTR)) Theravance Bio Pharma (TBPH) Gilead (GILD) Telaprevir Ocular Therapeutix (OCUL) Roche (RHHBY) Inovio (INO) Alnylam (ALNY) KERYX (KERX) AGOS (ARGS) ABBVIE (ABBV) NANTKWEST (NK) Genentech Ridaforolimus Benlysta (belimumab) CEMPRA (CEMP) TOKAI (TKAOI) Vitae Pharmaceuticals (VTAE) Adaptimmune (ADAP) Idenix (IDIX) Cytokinetics (CYTK) GlaxoSmithKline (GSK) Prosensa (RNA) Sanofi (SNA) Agenus (AGEN) Intrexon (XON) ARGOS (ARGS) Valeant Pharmaceuticals International (VRX) Ariad (ARIA) AstraZeneca (AZN) Anadys (ANDS) Spike Therapeutics (ONCE) INNOVIVA (INVA) Mirati Therapeutics (MRTX) Velcade (bortezomib) Tysabri C4 Therapeutics Regeneron (REGN) Ionis (IONS) Biogen Idec (BIIB) Merck (MRK) CRISPR Therapeutics (CRSP) JUNO (JUNO) SYNTA (SNTA) IDERA (IDRA) Herceptin Micromet (MITI) MODERNA Amgen (AMGN) Dendreon (DNDN) REGULUS (RGLS) Sangamo (SGMO) Incyte (INCY) Rapamune galapagos (GLPG) Bellicum (BLCM) HALOZYME (HALO) Onyx (ONXX) ADVENTRIX (ANX) Biocryst (BCRX) ARCA (ABIO)